Immunomodulatory properties of polysaccharide extract samples from Cyanobacterium sp. Rippka B-1200 Authors: Stanislav Sukhikh, Vladimir Popov, Egor Kashinskikh, Ekaterina Budenkova, Svetlana Ivanova, Olga Babich Published: 2024 ABSTRACT Cyanobacteria are most abundant in aquatic systems and can grow in freshwater, saline or brackish water, and cold/hot springs. Cyanobacteria have attracted considerable research attention in the last decade as a potential source of numerous biological products in large quantities, such as biofuels, pigments, polyunsaturated fatty acids, nutraceuticals, enzymes, and polysaccharides. Unlike most plant and fungal polysaccharides, the chemical composition, immunomodulatory activity, and molecular mechanisms of action of Cyanobacterium sp. Rippka B-1200 polysaccharides have been studied much less. The complexity of their primary structure due to the high variability of monosaccharides, their diverse bonds, the presence of substituents and high viscosity made detailed structural studies of cyanobacterial polysaccharides rare, which determines the need for analysis of cyanobacteria biomass components to identify active metabolites with promising biological activity. The aim of this study was to investigate the immunomodulatory properties of polysaccharides from Cyanobacterium sp. Rippka B-1200. Pharmacological and nutraceutical value of Cyanobacterium sp. Rippka B-1200 has been set, defining our study’s scientific novelty. As a result, the molecular weight of immunoactive polysaccharide (6.0–8.0 kDa) was determined. The analysis shows that endopolysaccharide samples at a concentration of 300 mg/kg showed no significant immunomodulatory effect (1.60 ± 0.15 mg/g), and the thymus mass index of animals in the experimental group was comparable to that of the control group in which animals were immunosuppressed with cyclophosphamide (1.15 ± 0.24 mg/g). When exopolysaccharide samples were used at a concentration of 600 mg/kg, the thymus mass index of animals in the experimental group (3.60 ± 0.32 mg/g) was statistically comparable to that of the control group (without polysaccharide) in which immunosuppression was not induced (thymus index was 3.70 ± 0.25 mg/g). It was found that endopolysaccharide samples at a concentration of 600 mg/kg also exhibited high immunomodulatory activity. When Cyanobacterium sp. Rippka B-1200 endopolysaccharide samples were used, no internal organ changes were observed in experimental animals after immunosuppression. The empirical results presented in the study may find application in the development of both pharmaceutical and cosmetic products. Cyanobacteria are unicellular photosynthetic microorganisms that convert solar energy into biomass, generally with greater efficiency than higher plants1. They are most abundant in aquatic environments and, unlike higher plants, can grow in freshwater, salty and/or brackish water, and cold/hot springs2. In the last decade, cyanobacteria have attracted considerable attention from researchers as a potential source of numerous biological products in large quantities, such as biofuels, pigments, polyunsaturated fatty acids, nutraceuticals, enzymes, and polysaccharides3,4. Cyanobacterial strains are well known for their ecological and metabolic diversity and have been continuously used for the production of biological molecules5,6. Polysaccharides are among such biological molecules produced by cyanobacteria that have wide applications in polymer and biological molecule-related industries as thickening/gel-forming agents and bioactive compounds, respectively7,8. In general, polysaccharides are complex carbohydrates that have different biochemical structures with different combinations of monosaccharides, aminosaccharides linked by glycosidic bonds in the presence of other functional groups such as sulfates, acyls, or amino acids on their backbones9. Based on the monomeric sugar composition, they are classified as homopolysaccharides (single monomeric sugar repeats in either linear or branched form) and heteropolysaccharides (multiple monomeric sugars in either linear or branched form)7. Polysaccharides are divided into endopolysaccharides (found inside the cyanobacterial cell) and exopolysaccharides (secreted by cyanobacteria into their environment). Cyanobacterial exopolysaccharides (EPS) are widely used in products such as gums, bioflocculants, biosorbents, and soil conditioners because of their unique potential biological activity10. Among the various microbial sources, cyanobacteria are well known as EPS producers11, have minimal nutrient requirements for growth2, and have the potential to utilize EPS in products with significant properties and characteristics12. Existing studies on this subject have shown that the biological activity of polysaccharides is closely related to their molecular weight13. Low-molecular-weight polysaccharides promote intermolecular interactions due to their ability to penetrate the cell membrane14. The immunostimulatory activity of polysaccharides was also found to be related to their molecular weight. It has been hypothesized that higher molecular weight contributes to low biological activity due to the increased number of sulfate groups in the broken chains15. High-molecular-weight polysaccharides cannot form active polymeric structures such as triple helical conformation, which hinders the bioavailability of polysaccharides16–18. Current research trends are focused on finding different strains of cyanobacteria19, characterizing them, and developing strategies to apply EPS production processes for commercial-scale use of these axenic cultures. The cultivation of axenic microalgae cultures in our study involves obtaining cultures with a single algal species free of other microorganisms20–22. The effect of cyanobacteria polysaccharide extract on adaptive immune responses has been demonstrated in vitro23,24. The next step is to test the properties of the extracts in vivo, as there are very few results of such studies presented25–27. This study aimed to characterize the endo- and exopolysaccharide samples of Cyanobacterium sp. and to evaluate their immunostimulatory effects. The present study focused on a comprehensive investigation of the immunomodulatory properties of polysaccharides from Cyanobacterium sp. Rippka B-1200. Our results confirmed that samples of primary intracellular and extracellular metabolites (polysaccharides) of Cyanobacterium sp. Rippka B-1200 possessed pronounced immunomodulatory properties, which opens the potential for their further application in the pharmaceutical and cosmetic fields, as well as for basic research on cyanobacteria. Results Determination of molecular weight and viscosity of polysaccharides The results of molecular weight and viscosity fractions of endopolysaccharide and exopolysaccharide samples are summarized in Table 1.Table 1Physical properties of the isolated polysaccharide samples from Cyanobacterium sp. Rippka B-1200.PolysaccharideMw (× 104 Da)Viscosity (mL/g)Exopolysaccharide5.86 ± 0.271.65 ± 0.14Endopolysaccharide18.47 ± 2.138.72 ± 0.36 Table 1Physical properties of the isolated polysaccharide samples from Cyanobacterium sp. Rippka B-1200.PolysaccharideMw (× 104 Da)Viscosity (mL/g)Exopolysaccharide5.86 ± 0.271.65 ± 0.14Endopolysaccharide18.47 ± 2.138.72 ± 0.36 Physical properties of the isolated polysaccharide samples from Cyanobacterium sp. Rippka B-1200. According to the empirical data (Table 1), it can be concluded that the molecular weight is higher in the endopolysaccharide sample group. A higher level of viscosity was also found for the cyanobacterium endopolysaccharide samples compared to the exopolysaccharide samples. Determination of the monosaccharide composition of polysaccharides by high-performance liquid chromatography The results of analyzing the monosaccharide composition of polysaccharides are presented in Table 2.Table 2Carbohydrate composition of isolated Cyanobacterium sp. Rippka B-1200 polysaccharide samples (µg/mL of extract).CarbohydrateExopolysaccharideEndopolysaccharideRhamnose10.00–Fucose–70.20Xylose–36.30Arabinose36.00110.00Fructose23.30–Glucose–127.20Galactose–372.00Sucrose16.0012.20Maltose31.2033.00Trehalose–33.10Raffinose––Mannose–– Table 2Carbohydrate composition of isolated Cyanobacterium sp. Rippka B-1200 polysaccharide samples (µg/mL of extract).CarbohydrateExopolysaccharideEndopolysaccharideRhamnose10.00–Fucose–70.20Xylose–36.30Arabinose36.00110.00Fructose23.30–Glucose–127.20Galactose–372.00Sucrose16.0012.20Maltose31.2033.00Trehalose–33.10Raffinose––Mannose–– Carbohydrate composition of isolated Cyanobacterium sp. Rippka B-1200 polysaccharide samples (µg/mL of extract). The exopolysaccharide samples (Table 2) contained arabinose, maltose, fructose, sucrose, and rhamnose, with arabinose and maltose predominating. The monosaccharide composition of endopolysaccharide samples isolated from cyanobacteria is mainly represented by galactose, glucose, arabinose and, to a lesser extent, fucose, xylose, maltose, trehalose, and sucrose. Testing the immunomodulatory effect of polysaccharides in vitro The results of evaluation of immunomodulatory effect of Cyanobacterium sp. Rippka B-1200 polysaccharide samples in vitro by ELISA are presented in Figs. 1 and 2.Fig. 1Morphology of Cyanobacterium sp. Rippka B-1200 (1000 × magnification, immersion).Fig. 2Growth dynamics of cyanobacterium. Morphology of Cyanobacterium sp. Rippka B-1200 (1000 × magnification, immersion). Growth dynamics of cyanobacterium. Evaluation of the mean values of the samples showed that there was a statistically significant difference between them (Kraskell–Wallis test, Table 3).Table 3Results of testing the significance of the effect of polysaccharide concentration on cytokine content.IndicatorConcentration, µg/mL10501050IL-1βTNF-αEmpirical values of the Kraskell–Wallis criterionz = 9.974; p = 0.019*z = 9.462; p = 0.024*z = 10.385; p = 0.016*z = 10.315; p = 0.016**p-value ≤ 0.05, intergroup difference is statistically significant. Table 3Results of testing the significance of the effect of polysaccharide concentration on cytokine content.IndicatorConcentration, µg/mL10501050IL-1βTNF-αEmpirical values of the Kraskell–Wallis criterionz = 9.974; p = 0.019*z = 9.462; p = 0.024*z = 10.385; p = 0.016*z = 10.315; p = 0.016**p-value ≤ 0.05, intergroup difference is statistically significant. Results of testing the significance of the effect of polysaccharide concentration on cytokine content. *p-value ≤ 0.05, intergroup difference is statistically significant. The subsequent analysis revealed that there was a statistically significant difference from the control group only in the group where the test animals were administered exopolysaccharide solution at a concentration of 600 mg/kg (Table 4).Table 4Results of intergroup comparison of IL-1β and TNF-α cytokine concentrations.Comparison groupsEndopolysaccharideExopolysaccharide10 µg/mL50 µg/mL10 µg/mL50 µg/mLIL-1β Positive controlz = − 1.964; p = 0.050*z = − 1.951; p = 0.050*z = − 1.963; p = 0.050*z = − 1.964; p = 0.050* Negative controlz = − 1.900; p = 0.050*z = − 1.964; p = 0.050*z = − 1.528; p = 0.127z = − 0.655; p = 0.513TNF-α Positive controlz = − 1.914; p = 0.050*z = − 1.562; p = 0.050*z = − 1.794; p = 0.050*z = − 2.913; p = 0.004* Negative controlz = − 1.754; p = 0.050*z = − 1.811; p = 0.050*z = − 1.974; p = 0.050*z = − 2.908; p = 0.004*Standardized Mann–Whitney criterion values and p value at α = 0,05; *p-value ≤ 0.050, intergroup difference is statistically significant. Table 4Results of intergroup comparison of IL-1β and TNF-α cytokine concentrations.Comparison groupsEndopolysaccharideExopolysaccharide10 µg/mL50 µg/mL10 µg/mL50 µg/mLIL-1β Positive controlz = − 1.964; p = 0.050*z = − 1.951; p = 0.050*z = − 1.963; p = 0.050*z = − 1.964; p = 0.050* Negative controlz = − 1.900; p = 0.050*z = − 1.964; p = 0.050*z = − 1.528; p = 0.127z = − 0.655; p = 0.513TNF-α Positive controlz = − 1.914; p = 0.050*z = − 1.562; p = 0.050*z = − 1.794; p = 0.050*z = − 2.913; p = 0.004* Negative controlz = − 1.754; p = 0.050*z = − 1.811; p = 0.050*z = − 1.974; p = 0.050*z = − 2.908; p = 0.004*Standardized Mann–Whitney criterion values and p value at α = 0,05; *p-value ≤ 0.050, intergroup difference is statistically significant. Results of intergroup comparison of IL-1β and TNF-α cytokine concentrations. Standardized Mann–Whitney criterion values and p value at α = 0,05; *p-value ≤ 0.050, intergroup difference is statistically significant. It was determined that the endopolysaccharide extract samples were statistically significantly anti-inflammatory and hence exhibited immunomodulatory activity in vitro. Testing the immunomodulatory effect of polysaccharides in vivo The results of the determination of the immunomodulatory effect of different concentrations of endopolysaccharide and exopolysaccharide of the studied cyanobacteria in vivo by the value of the visceral index of thymus and spleen of mice are presented in Figs. 3 and 4.Fig. 3Results of evaluating the immunomodulatory effect of polysaccharide samples of concentrations 10 µg/mL and 50 µg/mL in the presence of cytokines IL-β in vitro: Positive Control—monoclears with lipopolysaccharides; Negative Control—nutrient medium RPMI-1640; Endopolysaccharide and Exopolysaccharide—polysaccharide samples obtained from the biomass or from the culture liquid of Cyanobacterium sp. Rippka B-1200, respectively.Fig. 4Results of evaluating the immunomodulatory effect of polysaccharide samples of concentrations 10 µg/mL and 50 µg/mL in the presence of cytokines TNF-α in vitro: Positive Control—monoclears with lipopolysaccharides; Negative Control—nutrient medium RPMI-1640; Endopolysaccharide and Exopolysaccharide—polysaccharide samples obtained from the biomass or from the culture liquid of Cyanobacterium sp. Rippka B-1200, respectively. Results of evaluating the immunomodulatory effect of polysaccharide samples of concentrations 10 µg/mL and 50 µg/mL in the presence of cytokines IL-β in vitro: Positive Control—monoclears with lipopolysaccharides; Negative Control—nutrient medium RPMI-1640; Endopolysaccharide and Exopolysaccharide—polysaccharide samples obtained from the biomass or from the culture liquid of Cyanobacterium sp. Rippka B-1200, respectively. Results of evaluating the immunomodulatory effect of polysaccharide samples of concentrations 10 µg/mL and 50 µg/mL in the presence of cytokines TNF-α in vitro: Positive Control—monoclears with lipopolysaccharides; Negative Control—nutrient medium RPMI-1640; Endopolysaccharide and Exopolysaccharide—polysaccharide samples obtained from the biomass or from the culture liquid of Cyanobacterium sp. Rippka B-1200, respectively. Discussion The molecular weight of kelp polysaccharide, which had immune activity, was 6.0–8.0 kDa28. Two polysaccharide components with molecular masses of 126.9 kDa and 237 kDa were extracted from Chlorella ellipsoidea, respectively29,30. Carrageenan from the red algae Solieria chordalis with low molecular weight (< 20 kDa) also had higher immune activity31. At the appropriate molecular weight, β-glucans should have a more elongated chain conformation and exhibit stronger affinity for receptors on the cell surface, leading to higher immune activity32. The extracellular polysaccharide fraction isolated from Porphyridium cruentum with a molecular mass of 6.53 kDa had the strongest immunostimulatory activity, as evaluated in a mouse model with S180 tumors in vivo and peritoneal macrophage activation in vitro33. In addition to molecular weight, another important physical parameter is the viscosity of polysaccharides. The level of viscosity often correlates with the intensity of biological activity of polysaccharides. Polysaccharides with low viscosity may have better solubility in water34. In addition, the more branched the polysaccharide, the greater its biological activity35,36. This may be due to the fact that the large number of branchings directly affects the binding ability of polysaccharides to specific receptors37,38. For example, highly branched polysaccharides can stimulate macrophage function39. However, it was found that a polysaccharide with a small degree of branching could exhibit prominent immunostimulatory activity40, which was attributed to the higher solubility of the poorly branched polysaccharide22. Generally, a more complex monosaccharide composition accounts for better biological activity41. Georgiev et al.24 discovered that endopolysaccharides derived from cyanobacteria, which had an immunomodulatory effect ex vivo, were composed of glucose (21.4–38.6%), galactose (9.8–45.0%), and xylose (10.1–12.5%). In a study by Olafsdottir et al.42, the monosaccharide composition of the exopolysaccharide of Nostoc sp. was defined as the ratio of Glc/GlcA/Xyl/Man/Ara/Rib/Gal (24:24:15:13:7:4). In another study43, the monosaccharide composition of Nostoc sp. exopolysaccharide with immunomodulatory properties included mainly arabinose (18.6%), glucose (19.7%), mannose (19.1%), xylose (15.3%), and uronic acids (25.0%). When endopolysaccharide samples were used at a concentration of 10 µg/mL (Figs. 1 and 2), the content of cytokines IL-1β and TNF-α in the reaction medium reached 236.90 ± 13.10 pg/mL and 17.83 ± 1.81 pg/mL, respectively. When polysaccharide concentration was increased to 50 µg/mL, cytokine IL-1β decreased (118.53 ± 20.91 µg/mL), while cytokine TNF-α increased (27.98 ± 1.12 µg/mL). The cytokine concentration levels with the endopolysaccharides studied were statistically significantly higher than the cytokine contents observed in the positive control (412.65 ± 20.61 µg/mL for IL-1β and 31.41 ± 1.58 µg/mL for TNF-α) and negative control (21.15 ± 11.50 µg/mL for IL-1β and 7.20 ± 1.43 µg/mL for TNF-α). Analysis of the results (Tables 3, 4) showed that endopolysaccharide samples at a concentration of 300 mg/kg had no immunomodulatory effect (1.60 ± 0.15 mg/g), and the thymus mass index of animals in the experimental group was comparable to that of the control group in which animals were immunosuppressed with cyclophosphamide (1.15 ± 0.24 mg/g). Using a sample of exopolysaccharide at a concentration of 600 mg/kg, the thymus mass index of animals in the experimental group (3.60 ± 0.32 mg/g) was statistically comparable to that of the control group in which immunosuppression was not induced (thymus index was 3.70 ± 0.25 mg/g). For spleen weight index, the use of endopolysaccharide samples at a concentration of 300 mg/kg was found to be less effective (3.30 ± 0.25 mg/g) than the use of exopolysaccharide samples at a concentration of 600 mg/kg. In the latter case, the spleen index was 5.50 ± 0.49 mg/g, which was comparable to that of the control group in which animals did not receive cyclophosphamide (5.70 ± 1.18 mg/g and 3.70 ± 0.25 mg/g for spleen and thymus, respectively). Empirical data (Figs. 1 and 2) indicate that when endopolysaccharide samples were administered at a concentration of 300 mg/kg, there was a change in the visceral index of thymus and spleen in laboratory animals comparable to that in the control group receiving cyclophosphamide. The thymus index for the groups of animals receiving the exopolysaccharide samples averaged 1.2 ± 0.19 mg/g at 300 mg/g and 1.3 ± 0.36 mg/g at 600 mg/g, which was also statistically consistent with the negative control, where the thymus index was 3.7 ± 0.25 mg/g. The visceral index of the spleen in animals from the group receiving exopolysaccharide samples at a concentration of 300 mg/kg was 2.9 ± 0.28 mg/g and at a concentration of 600 mg/kg was 3.2 ± 0.38 mg/g. Comparing the values of the results of the experimental groups with those of the negative control group, it can be summarized that the studied samples of exopolysaccharide had no immunomodulatory effect, both at a concentration of 300 mg/kg and 600 mg/kg of body weight. The findings are consistent with the results of similar studies published in research articles. Thus, Yim et al.44 studied the immunostimulatory effect of sulfated exopolysaccharide by isolating peritoneal macrophages from mice 10 or 20 days after they received a single dose of p-KG03 (100 or 200 mg/kg of body weight). As a result, nonspecific immune functions mediated by natural killer cells and macrophages were enhanced. The immunomodulatory activity of the polysaccharides derived from Chlorella pyrenoidosa has been demonstrated when they were administered to male mice. Oral administration of C. pyrenoidosa polysaccharides, 1 and 2 g/kg of body weight, significantly increased phagocytic rate (23.00 and 26.25%, respectively) and phagocytic index (0.30 and 0.36, respectively) compared to saline-treated controls45. Thus, samples of polysaccharides isolated from the Cyanobacterium sp. Rippka B-1200 were tested for their immunomodulatory effects in vitro and in vivo. It was found that endopolysaccharide samples at a concentration of 600 mg/kg exhibited the desired immunomodulatory activity. When endopolysaccharide samples were used at the above concentration, no internal organ changes were observed in experimental animals after immunosuppression, and visceral organ indices were similar to those of the native control group. Conclusion As a result of this study, it can be concluded that the samples of Cyanobacterium sp. Rippka B-1200 endopolysaccharide had an immunomodulatory effect that was statistically significant in both in vitro and in vivo experiments. The obtained samples of unfractionated endopolysaccharide extract had a molecular mass of (18.47 ± 2.13) × 104 Da and the monosaccharide composition was dominated by such components as galactose, glucose, and arabinose. In the in vitro experiment, the studied endopolysaccharide extracts (10 µg/mL) showed immunomodulatory activity, which was manifested by decreased levels of cytokines IL-1β and TNF-α compared to the control group. The immunomodulatory effect of endopolysaccharide samples was also found in rodent experiment. When animals were intraperitoneally injected with a solution of endopolysaccharide samples at a concentration of 600 mg/kg, a leveling off of the previously administered immunosuppressant was observed (visceral indices of thymus and spleen were comparable to those in the negative control group). The empirical results presented in this study may find application in the field of pharmaceuticals and cosmetology. Methods and materials Cyanobacteria cultivation conditions The Cyanobacterium sp. Rippka et Cohen-Bazire with a collection number B-1200 (Fig. 5) (K.A. Timiryazev Institute of Plant Physiology, Russian Academy of Sciences, Moscow, Russia), served as the object of the study. Cyanobacterium sp. Rippka (https://cellreg.org/Catalog_2020/Catalog%20NEW/IPPAS%20B-1200.html) is represented by single or paired elongated green colored cells. This strain has been identified relatively recently; phylogenetic affiliation of the strain was determined by sequencing the RNA gene encoding 16S protein synthesis:) Bacteria; Cyanobacteriota; Cyanophyceae; Oscillatoriophycideae; Chroococcales; Geminocystaceae; Cyanobacterium, but species affiliation has not been determined (https://www.ncbi.nlm.nih.gov/nuccore/KM502966). The cultivated microalgae were axenic. Cultivation in Erlenmeyer flasks 2L (working volume 1L) with autoclaved Zarrouk’s nutrient medium without modifications was used46. Cultivation was performed under white light conditions (LEDVANCE, China) at 34 ± 1 °C, white light with photoperiod 12:12 h and an intensity 100 ± 10 µmol·photon·m−2 s−1. Cultivation for two weeks. Samples were taken every day to plot the growth curve. The growth curve was evaluated spectrophotometrically at OD750. The cultivation was carried out under sterile conditions. Contamination control by regular microscopy (Optika, Italy).Fig. 5Visceral index of organs (thymus and spleen) when endopolysaccharide samples were administered to animals: Positive Control—group of animals with immunosuppressor (cyclophosphamide 45 mg/g) administered; Negative Control—native group of animals (without immunosuppressor administration); 300 mg/g—group of animals with administration of exopolysaccharide solution, concentration 300 mg/kg, after immunosuppressor administration; 600 mg/g—group of animals with administration of exopolysaccharide solution, concentration 600 mg/kg after immunosuppressor administration. Visceral index of organs (thymus and spleen) when endopolysaccharide samples were administered to animals: Positive Control—group of animals with immunosuppressor (cyclophosphamide 45 mg/g) administered; Negative Control—native group of animals (without immunosuppressor administration); 300 mg/g—group of animals with administration of exopolysaccharide solution, concentration 300 mg/kg, after immunosuppressor administration; 600 mg/g—group of animals with administration of exopolysaccharide solution, concentration 600 mg/kg after immunosuppressor administration. Polysaccharide production Samples of extracellular polysaccharides (exopolysaccharides) synthesized by cyanobacteria were obtained by ethanol precipitation from culture liquid on the 14th day of cultivation (Fig. 6)47. The cyanobacteria suspension was centrifuged (Eppendorf 5810 R, Germany) at 1503 × g for 20 min. The resulting culture liquid (supernatant) was combined with chilled ethanol at a ratio of 1:2 (vol:vol) and left at + 4 °C for 2–3 h, after which it was centrifuged again at 1503 × g for 10 min. The precipitate (exopolysaccharides) was dialyzed in Spectra/Por4 12–14 kDa dialysis bags (Spectrum Labs Inc, USA) for 24 h against distilled water and then dried in a Freezone Triad lyophilic dryer (LABCONCO, USA).Fig. 6Visceral index of organs (thymus and spleen) when exopolysaccharide samples were administered to animals: Positive Control—group of animals with immunosuppressor (cyclophosphamide 45 mg/g) administered; Negative Control—native group of animals (without immunosuppressor administration); 300 mg/g—group of animals with administration of exopolysaccharide solution, concentration 300 mg/kg, after immunosuppressor administration; 600 mg/g—group of animals with administration of exopolysaccharide solution, concentration 600 mg/kg after immunosuppressor administration. Visceral index of organs (thymus and spleen) when exopolysaccharide samples were administered to animals: Positive Control—group of animals with immunosuppressor (cyclophosphamide 45 mg/g) administered; Negative Control—native group of animals (without immunosuppressor administration); 300 mg/g—group of animals with administration of exopolysaccharide solution, concentration 300 mg/kg, after immunosuppressor administration; 600 mg/g—group of animals with administration of exopolysaccharide solution, concentration 600 mg/kg after immunosuppressor administration. To obtain endopolysaccharide samples, the cyanobacteria suspension was centrifuged (Eppendorf 5810 R, Germany) at 1503 × g for 20 min, the biomass was dried in a Freezone Triad lyophilic dryer (LABCONCO, USA) at − 80 °C and 5 Pa until the samples were completely dried and then after weighing were dissolved in distilled water. The cell suspension was treated with ultrasound (130 Watt, 20 kHz, Ampl. 53%) on an ultrasonic homogenizer (Ultrasonic processor, Cole Parmer, USA) to disrupt the cells, then centrifuged. The supernatant was fractionated using an organic solvent (mixture of chloroform and n-butanol, 4:1), after which the fraction containing carbohydrates was selected and deproteinized using the Sevag method48. The liquid containing endocarbohydrates was dialyzed in Spectra/Por4 12–14 kDa dialysis bags (Spectrum Labs Inc., USA) for 24 h against distilled water, centrifuged, and the samples dried to complete dryness under the same conditions. Determination of molecular weight and viscosity of polysaccharides Molecular mass was determined by gel permeation chromatography (GPC) using Sephadex G 150 gel (Sigma, USA) as excipient. Dextrans with different molecular weights (T-10, T-40, T-70, T-500) were used as molecular standards. The molecular weight of polysaccharides was estimated according to the method49. GPC was performed by eluting with phosphate-salt buffer (PBS, 0.2 mol/L) at a flow rate of 6 mL/h. The total carbohydrate content of each sample was estimated by phenol–sulfuric acid method49. The molecular mass of each fraction was determined using a regression of a calibration plot of the molecular masses of standard dextran samples. The average molecular weight of polysaccharides was calculated using the following equation:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Mw = \frac{{\Sigma M_{i} C_{i} }}{{\Sigma C{\text{i}}}},$$\end{document}where \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$M_{i}$$\end{document}—molecular weight of each fraction, Da; Ci—total carbohydrate concentration in each fraction, mg/mL. To study viscosity, samples were evaporated in a Hei-VAP Precision HL/G3 rotary evaporator (Heidolph, Germany) and lyophilized in a Triad lyophilic drying unit (Labconco, USA). The viscosity of exopolysaccharide and endopolysaccharide samples was evaluated according to50. A Ubbelohde ASTM glass capillary viscometer (Fungilab, Spain) with a capillary diameter of 0.82 mm was used for viscosity estimation. Lyophilized polysaccharide fractions were dissolved in 0.2 molar phosphate buffer, centrifuged at 1150 × g and filtered through a membrane filter with a pore diameter of 0.45 μm. Viscosity was determined at an ambient temperature of 25.0 ± 0.5 °C. Relative viscosity (ηr) was calculated using the following formula:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\eta_{r} = \frac{\eta }{{\eta_{0} }},$$\end{document}where η0—solvent viscosity, cP; η—solution viscosity at the same temperature, cP. The measured viscosities were converted to specific viscosity (ηsp, sP):\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\eta_{sp} = \frac{{\eta - \eta_{0} }}{{\eta_{0} }} = \eta_{r} - 1.$$\end{document} Determination of the monosaccharide composition of polysaccharides by high-performance liquid chromatography Sample preparation for HPLC consisted of acid hydrolysis of polysaccharides: 3 ml of 20% trifluoroacetic acid solution was added to a 10 mg weight of polysaccharides. The hydrolysis process was performed for 1 h at 120 °C. Trifluoroacetic acid (TFA) was then distilled off using a rotary evaporator and re-extracted with the addition of 500 μL of isopropyl alcohol to the reaction mixture. The purified hydrolysate was dissolved in 3 mL of distilled water, centrifuged for 5 min at 1150 × g and filtered through a syringe filter with a pore diameter of 22 μm. LC-20AB Prominence liquid chromatograph (Shimadzu, Japan) with binary pump and SPD-M20A diode matrix detector and Supelco 4.6 × 250 mm 5 µm amino phase column were used. The separation was performed at 30 °C in isocratic elution mode at a wavelength of 192 nm, with a flow rate of 1 mL/min. Acetonitrile and bidistilled water were used as mobile phase. The sample volume was 5 μL. The components were identified by retention times and spectra of individual standard substances. Testing the immunomodulatory effect of polysaccharides in vitro Anti-inflammatory properties of polysaccharides were determined by solid-phase enzyme-linked immunosorbent assay (ELISA) on a Mindray MR-96A analyzer (Mindray, China). Control and studied samples of polysaccharides were incubated in wells in RPMI-1640 nutrient medium (Sigma, USA), in the presence of immobilized monoclonal antibodies (mononuclear cells), with the first conjugate (polyclonal antibodies to human cytokines with biotin), with the second conjugate (streptavidin with horseradish peroxidase). The amount of bound second conjugate was determined by color reaction (at 450 nm) using horseradish peroxidase substrate—hydrogen peroxide and chromogen—tetramethylbenzidine51. The anti-inflammatory properties of polysaccharide samples isolated from cyanobacterium were evaluated at concentrations of 10 and 50 μg/mL. The concentration of IL-1β and TNF-α produced was determined. The ELISA procedure was performed according to the protocol of commercial kit manufacturers (Sigma, USA). Nutrient medium was used as a negative control. The positive control was monoclears with lipopolysaccharides. Testing the immunomodulatory effect of polysaccharides in vivo I-Management of laboratory animals Male mice from Pushchino breeding station (Laboratory Animal Breeding “Pushchino”, Pushchino, Russia) were used for the study. The animals were managed in accordance with the rules adopted in the European Convention for the Protection of Vertebrate Animals52,53, and also conformed to the rules of laboratory practice (GLP) and the Order of the Ministry of Health of the Russian Federation No267 of 19.06. 2003 “On Approval of the Rules of Laboratory Practice”. Experimental manipulations were performed in the morning in compliance with the rules for humane treatment of laboratory animals. Laboratory animals (20 male C57Bl/6 J mice) were kept in a specialized room. Indoor air quality has been controlled in compliance with environmental parameters. The room air temperature was 22 ± 4 °C, humidity 46–65%, air exchange regime of 10–15 room volumes per hour. Light and dark phases alternated every 12 h. The animals underwent a 3-day adaptation period. Mice were kept in standard polycarbonate cages on open stainless steel racks. Animals were housed in stable social groups of no more than 5 animals. Fine hardwood chips were used as bedding. The cages were covered with stainless steel lattice covers with a feeding recess. The floor area per animal was in accordance with regulatory standards54. Animals were provided access to food in a special cage recess and water in standard drinkers with stainless steel spout lids ad libitum. Feed for laboratory animals PK-120–1 was prepared according to GOST 34566–2019 “Complete mixed feeds for laboratory animals. Specifications”55. The mixed fodder (Laboratorkorm, Russia) had the following composition of pellets: cereals (wheat, barley, oats), grains, products of plant origin and products of their processing (wheat bran), meat and animal by-products (meat and bone meal), sunflower meal, vitamins, and minerals (premix). Water was treated and normalized according to SanPiN 2.1.3684-21 “Sanitary and Epidemiological Requirements for the maintenance of urban and rural settlements, water bodies, drinking water and drinking water supply to the population, air, soil, living quarters, operation of industrial and public premises, organization and conduct of sanitary and anti-epidemic (preventive) measures”. Application №158 for managing laboratory animals and conducting experiments was approved during the Lomonosov Moscow State University Bioethics Commission meeting (No. 154-d, 17.08.2023). The study is reported in accordance with ARRIVE guidelines. All methods were performed in accordance with the relevant guidelines and regulations. II-Formation of an immunosuppression model A method based on the use of cyclophosphamide, a medication that induces immunosuppressive activity, was applied. Cyclophosphamide is used in anticancer therapy but has serious side effects such as immunosuppression and myelosuppression due to DNA damage to normal cells56,57. Due to the fact that polysaccharides were poorly soluble in common solvents, the samples were subjected to hydrolysis for study. The hydrolysis products of polysaccharides are readily soluble in water because of their shorter chain58,59. During the experiments, the mass index of the spleen and thymus was evaluated as an index reflecting the immune function of the organism and immune prognosis60. Groups of mice included 5 males each. Mice were randomly divided into groups (5 animals each): control group 1 (positive control)—immunosuppressor medication administration, no polysaccharide administration; control group 2 (negative control)—no immunosuppressor medication administration, no polysaccharide administration; experimental groups—immunosuppressor medication administration, polysaccharide (endopolysaccharide or exopolysaccharide) administration. To form a model of immunosuppression, animals of the control group №1 and experimental groups were injected intraperitoneally with an immunosuppressor medication (cyclophosphamide, 45 mg/kg), once a day for 5 days. On day 10, the experimental group was injected intraperitoneally with a solution of polysaccharide (endopolysaccharide or exopolysaccharide) of cyanobacteria (300 or 600 mg/kg of body weight). On day 14 after polysaccharide administration, the body weight of animals in all groups was measured, the animals were euthanized to inhalation using CO2, and their spleens and thymi were surgically removed. Organs were weighed and visceral index was calculated as the ratio of organ weight (mg) to total body weight (g). Statistical methods Study data are presented as median ± standard deviation. Statistical analysis and graphical presentation of experimental data were performed in IBM SPSS Statistics (version 23.0, 2021, SPSS: An IBM Company, San Francisco, California, USA) and using Statistica 10.0 software (StatSoft, USA). Statistical processing of the experimental material was performed using nonparametric criteria (Kraskal-Wallace analysis of variance, Mann–Whitney test for comparison of two independent samples with Bonferroni correction for multiplicity of comparison, Wilcoxon test for comparison of two dependent samples). The results of statistical analysis are presented by criterion value and p-value (< 0.05).